UHMS Facility Accreditation: What It Signals to Patients

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

The Undersea & Hyperbaric Medical Society (UHMS) has published 14 editions of its "Hyperbaric Oxygen Therapy Indications" report, guiding clinical practice, with the 14th edition documented in UHMS-14thEd.indb on page v.
UHMS accreditation helps identify facilities that meet standards for treating specific illnesses with hyperbaric oxygen therapy, as recommended by the FDA.
Hyperbaric oxygen therapy is defined as breathing 100% oxygen at pressures greater than 1 atmosphere absolute.
Conditions like air or gas embolism, carbon monoxide poisoning, and severe anemia are among the indications for HBOT, with gas embolism occurring from an ascent of as little as one meter in divers, as noted in the HBO Indications (2020) - Undersea & Hyperbaric Medical Society.

When you are considering hyperbaric oxygen therapy (HBOT), understanding UHMS accreditation is very important. This accreditation comes from the Undersea & Hyperbaric Medical Society, a leading authority in hyperbaric medicine. It tells patients that a facility meets strict standards for safety and quality in providing HBOT. The FDA even recommends UHMS-accredited hyperbaric facilities for treating specific illnesses, as highlighted in a news announcement from the Undersea & Hyperbaric Medical Society. We know that hyperbaric oxygen therapy involves breathing pure oxygen at increased pressures, which can help the body heal. The UHMS has carefully reviewed and approved 14 specific conditions for which HBOT is an accepted treatment, detailed across 14 editions of its "Hyperbaric Oxygen Therapy Indications" report. For instance, the 13th edition of this report was chaired and edited by Lindell K. Weaver, MD, providing a strong foundation for clinical guidelines.

What is UHMS Accreditation?

UHMS accreditation is a recognition from the Undersea & Hyperbaric Medical Society. It signals that a hyperbaric facility meets established standards for patient care and safety. This means the clinic has been evaluated to ensure it follows best practices in hyperbaric medicine. The FDA recommends UHMS-accredited hyperbaric facilities for treating specific illnesses, according to a news announcement from the Undersea & Hyperbaric Medical Society. This recommendation underscores the importance of this accreditation for patient safety and effective treatment.

The Role of the Undersea & Hyperbaric Medical Society

The Undersea & Hyperbaric Medical Society (UHMS) is a non-profit organization focused on hyperbaric and diving medicine. They develop guidelines and educational programs. Their work includes publishing reports like the "Hyperbaric Oxygen Therapy Indications," which is now in its 14th edition, as noted in the preface of UHMS-14thEd.indb. This document outlines the conditions for which HBOT is considered an accepted medical treatment. The UHMS also offers training and certification for medical professionals in the field. This commitment to education and standards helps ensure that patients receive high-quality care.

How Facilities Achieve Accreditation

For a hyperbaric facility to earn UHMS accreditation, it must undergo a thorough review process. This process examines many aspects of the facility's operations. It looks at the qualifications of the medical staff, the safety protocols for operating hyperbaric chambers, and the overall quality of patient care. The facility must demonstrate that it can safely and effectively provide hyperbaric oxygen therapy for the conditions recognized by the UHMS. This includes having proper equipment, such as hyperbaric chambers, and trained personnel who understand the specific needs of patients undergoing HBOT. The goal is to ensure that every patient receives care that meets the highest medical standards.

Why FDA Recommendation Matters

The U.S. Food & Drug Administration (FDA) is responsible for protecting public health. When the FDA recommends UHMS-accredited hyperbaric facilities for treating specific illnesses, it adds a significant layer of trust for patients. This recommendation means that the FDA recognizes the UHMS's rigorous standards. It suggests that facilities meeting these standards are reliable for treating certain health problems with HBOT. This is especially important because hyperbaric oxygen therapy involves specialized equipment and procedures. Patients can feel more confident knowing that a facility has met both UHMS standards and received an FDA recommendation for specific treatments. This dual recognition helps patients make informed decisions about their healthcare.

Benefits of Accreditation for Patients

Choosing a UHMS-accredited facility offers several benefits for patients. First, it provides assurance of safety. Hyperbaric chambers operate under increased pressure, and proper safety protocols are essential. Accreditation means the facility has been checked for these safety measures. Second, it signals quality of care. The UHMS evaluates staff training, equipment maintenance, and treatment protocols. This helps ensure that patients receive effective therapy from qualified professionals. Third, it helps with insurance coverage. While not guaranteed, treatments for UHMS-approved indications at accredited facilities are more likely to be covered by insurance. This is because accreditation demonstrates adherence to recognized medical guidelines. Patients can trust that an accredited facility is committed to their well-being and to providing care that aligns with established medical evidence.

What Conditions Does the UHMS Recognize for Hyperbaric Oxygen Therapy?

The UHMS publishes a list of conditions for which hyperbaric oxygen therapy (HBOT) is an accepted treatment. This list helps guide medical professionals and patients on appropriate uses of HBOT. The "Hyperbaric Oxygen Therapy Indications" report is now in its 14th edition, as detailed in the preface of UHMS-14thEd.indb. This means the UHMS regularly reviews and updates its recommendations based on the latest scientific evidence.

The Evolution of UHMS Indications

The UHMS has a long history of evaluating and defining the appropriate uses of HBOT. Their "Hyperbaric Oxygen Therapy Indications" report is a cornerstone of this effort. The 13th edition of the report was chaired and edited by Lindell K. Weaver, MD, as noted in the front matter of UHMS_HBO2_Indications_13th_Ed._Front_Matter__References.pdf. The continuous updates, now reaching the 14th edition, show the society's dedication to keeping pace with research and clinical experience. Each edition involves a detailed review process by experts in hyperbaric medicine. This process ensures that only conditions with strong scientific backing are included in the official list of indications. The UHMS aims to provide clear, evidence-based guidance for healthcare providers and patients.

How New Indications Are Added

The UHMS has a formal process for accepting new indications for hyperbaric oxygen therapy. This process involves careful review of scientific literature and clinical data. Experts on the Hyperbaric Oxygen Therapy Committee evaluate research studies to determine if there is enough evidence to support the effectiveness of HBOT for a new condition. They look for consistent results from well-designed studies. This rigorous approach maintains the credibility of the UHMS's recommendations. It ensures that the list of approved indications is based on sound medical science, not anecdotal evidence or unproven claims. The UHMS is committed to promoting responsible and effective use of HBOT.

Understanding the "Hyperbaric Oxygen Therapy Indications" Report

The "Hyperbaric Oxygen Therapy Indications" report is a comprehensive document. It details each of the approved conditions, explaining why HBOT is beneficial and how it should be administered. The report includes background information, definitions of hyperbaric oxygen, and utilization review guidelines. It also features a list of abbreviations and author biographies, providing transparency about the experts involved. This report serves as a critical reference for anyone involved in hyperbaric medicine. For patients, it offers insight into the specific conditions that HBOT can effectively treat, helping them understand if the therapy is right for their diagnosis. The report is an essential tool for ensuring consistent and high-quality care across hyperbaric facilities.

Importance of Evidence-Based Practice

The UHMS's focus on evidence-based indications is crucial for patient safety and effective treatment. By only recognizing conditions with strong scientific support, the UHMS helps prevent the use of HBOT for unproven claims. This protects patients from ineffective treatments and potential risks. It also guides healthcare providers in making informed decisions about when to prescribe HBOT. The society emphasizes that any suggested test or procedure should only be carried out if, in the reader’s judgment, its risk is justified, and recommends independent verification of diagnoses and drug dosages due to rapid advances in medical sciences, as stated in the 13th Edition report. This commitment to evidence-based practice is a core principle of the UHMS and its accreditation program. It reinforces the idea that medical treatments should be grounded in solid research and clinical outcomes. For a current snapshot of how that evidence bar is being tested—using long COVID as the case study—see HBOT for Long COVID in 2026: Where Studies Stand.

The 14 Approved Indications

The UHMS currently recognizes 14 primary indications for hyperbaric oxygen therapy. These are conditions where HBOT has been shown to be effective through scientific research. The list includes a range of acute and chronic conditions, from emergencies like carbon monoxide poisoning to chronic issues like problem wounds. Each indication has specific protocols for treatment, including the pressure of oxygen, the duration of sessions, and the number of treatments. These protocols are designed to maximize the therapeutic benefits while minimizing risks. Knowing these approved indications helps patients understand if their condition is one that HBOT can legitimately address, especially when seeking care at an accredited facility.

What are the Approved Indications for HBOT?

There are 14 primary indications for hyperbaric oxygen therapy recognized by the UHMS. These include conditions like air or gas embolism and carbon monoxide poisoning. Other indications cover problem wounds, compromised grafts, and certain infections. The UHMS lists these 14 specific indications for hyperbaric oxygen therapy in Part I of UHMS-14thEd.indb, providing detailed guidance for each.

1. Air or Gas Embolism

Gas embolism happens when gas bubbles enter arteries or veins. Arterial gas embolism (AGE) was first described during submarine escape training. This happened when pulmonary barotrauma occurred during a free ascent after breathing compressed gas at depth. Pulmonary barotrauma and gas embolism can happen from breath holding during an ascent of as little as one meter, as noted by Richard E. Moon in the "Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism" section of the UHMS resources. AGE has also been linked to normal ascents in divers with lung problems like bullous disease and asthma. Pulmonary barotrauma can result from blast injury, mechanical ventilation, penetrating chest trauma, chest tube placement, and bronchoscopy.

Venous gas embolism (VGE) is common after compressed gas diving. Normally, VGE bubbles get trapped by the lung capillaries and do not cause symptoms. However, large amounts of VGE can cause cough, shortness of breath, and pulmonary edema. It can also overwhelm the lung capillaries, letting bubbles enter the arterial circulation. VGE can also go directly into the left side of the heart through an atrial septal defect or patent foramen ovale. For more details, see UHMS Hyperbaric Oxygen Therapy Indications, 14th Edition.

Other causes of gas embolism, besides diving, include accidental intravenous air injection, cardiopulmonary bypass accidents, lung needle biopsy, hemodialysis, central venous catheter placement or disconnection, gastrointestinal endoscopy, hydrogen peroxide irrigation or ingestion, arthroscopy, cardiopulmonary resuscitation, percutaneous hepatic puncture, blowing air into the vagina during orogenital sex, and sexual intercourse after childbirth. Air embolism can happen during surgeries where the site is under pressure, such as laparoscopy, transurethral surgery, vitrectomy, endoscopic vein harvesting, and hysteroscopy. Massive VGE can also occur when air passively enters surgical wounds that are higher than the heart, causing pressure in nearby veins to be lower than atmospheric pressure. This has been seen in sitting craniotomy, cesarean section, prostatectomy, spine surgery, hip replacement, liver resection, liver transplantation, and dental implant insertion. Even small amounts of air injected into arteries can cause problems, while intravenous injection is often asymptomatic. In experiments, animals tolerated up to 0.5-1 mL/kg. In humans, a continuous intravenous infusion of oxygen at 10 mL/min was tolerated, but 20 mL/min caused symptoms, as detailed in the HBO Indications (2020) - Undersea & Hyperbaric Medical Society. Injections of air are more likely to cause clinical problems than constant infusions.

2. Arterial Insufficiencies

This category includes conditions where there isn't enough blood flow to arteries. Hyperbaric oxygen therapy is used for Central Retinal Artery Occlusion and for selected problem wounds, as listed in the 14th edition of the UHMS indications. For example, problem wounds that have trouble healing due to poor circulation can benefit from the increased oxygen delivered by HBOT. This enhanced oxygen delivery helps to promote tissue repair and growth.

3. Carbon Monoxide Poisoning

Carbon monoxide is a colorless, odorless gas that can be deadly. When inhaled, it binds to red blood cells much more readily than oxygen, preventing oxygen from reaching the body's tissues. HBOT helps by rapidly removing carbon monoxide from the blood and delivering high levels of oxygen to the body. This is a critical emergency indication for hyperbaric therapy.

4. Clostridial Myonecrosis (Gas Gangrene)

This is a severe and rapidly progressing bacterial infection that destroys muscle tissue. The bacteria that cause gas gangrene thrive in low-oxygen environments. HBOT helps by delivering high concentrations of oxygen to the infected tissues, which directly inhibits the growth of these bacteria and helps the body's immune system fight the infection.

5. Compromised Grafts and Flaps

When tissues are transplanted, such as skin grafts or surgical flaps, they need a good blood supply to survive. If the blood flow is poor, the graft or flap can become compromised and die. HBOT can help improve oxygen delivery to these tissues, increasing their chances of survival and successful integration.

6. Acute Traumatic Ischemias

This refers to sudden lack of blood flow to tissues due to trauma. Conditions like crush injuries can lead to severe swelling and reduced blood supply, risking tissue death. HBOT can reduce swelling and deliver oxygen to damaged tissues, helping to preserve limbs and promote healing.

7. Decompression Sickness

Commonly known as "the bends," decompression sickness affects divers who ascend too quickly. Gas bubbles form in the blood and tissues, causing pain, neurological symptoms, and even death. HBOT works by recompressing the body, shrinking the bubbles, and allowing them to dissolve safely back into the blood, from where they can be exhaled.

8. Delayed Radiation Injuries (Soft Tissue and Bony Necrosis)

Radiation therapy, while life-saving for cancer, can sometimes damage healthy tissues, leading to chronic wounds, bone death (necrosis), and other problems months or years later. HBOT can help repair these damaged tissues by promoting new blood vessel growth and increasing oxygen supply to the affected areas.

9. Sudden Sensorineural Hearing Loss

This condition involves a rapid loss of hearing, often in one ear. While the exact cause can vary, HBOT has been shown to improve outcomes by increasing oxygen delivery to the inner ear, which can help preserve and restore hearing function.

10. Intracranial Abscess

An intracranial abscess is a collection of pus within the brain. These infections can be very serious. HBOT can be used as an adjunctive treatment to antibiotics, helping to deliver more oxygen to the infected area, which can enhance the effectiveness of antibiotics and aid in healing. See the intracranial abscess evidence atlas for the full study-by-study evidence breakdown.

11. Necrotizing Soft Tissue Infections

These are severe, rapidly spreading infections that destroy skin, fat, and muscle. Like gas gangrene, these infections thrive in low-oxygen environments. HBOT provides high levels of oxygen to these tissues, which helps to kill the bacteria and prevent further tissue destruction.

12. Refractory Osteomyelitis

Osteomyelitis is an infection of the bone. When it doesn't respond to standard treatments (refractory), HBOT can be an effective adjunct. The increased oxygen helps to fight the infection in bone tissue, where blood supply can be limited, and promotes bone healing.

13. Severe Anemia

In cases of severe anemia where a blood transfusion is not possible or is delayed, HBOT can be life-saving. By dissolving large amounts of oxygen directly into the blood plasma, HBOT can temporarily provide enough oxygen to the body's tissues even with a low red blood cell count. See the severe anemia evidence atlas for the full study-by-study evidence breakdown.

14. Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns

Severe burns can lead to tissue damage, swelling, and infection. HBOT can be used alongside other burn treatments to reduce swelling, promote healing, fight infection, and potentially reduce the need for surgery by improving the viability of damaged tissues.

Why is UHMS Accreditation Important for Patients?

Accreditation helps patients identify clinics that adhere to recognized medical standards. It provides assurance that the facility is equipped and staffed to provide safe and effective HBOT. The FDA specifically recommends UHMS-accredited facilities for treatment of certain illnesses, as highlighted in a news announcement from the Undersea & Hyperbaric Medical Society. This makes UHMS accreditation a critical benchmark for patient choice. For more details, see FDA recommends UHMS-accredited hyperbaric facilities.

Ensuring Safety in Treatment

Hyperbaric oxygen therapy involves placing patients in a chamber where they breathe 100% oxygen at pressures greater than typical atmospheric pressure. This environment requires strict safety protocols to prevent complications. UHMS accreditation means that a facility has been vetted for these safety measures. It ensures that the hyperbaric chambers are maintained correctly, staff are trained in emergency procedures, and all aspects of treatment are conducted with patient well-being as the top priority. Without such accreditation, patients might be exposed to facilities that do not meet these essential safety standards, potentially increasing risks.

Guaranteeing Qualified Staff and Equipment

A UHMS-accredited facility must demonstrate that its medical staff are properly trained and certified in hyperbaric medicine. This includes physicians, nurses, and hyperbaric technicians. These professionals understand the complex physiology of hyperbaric treatment and how to manage potential side effects. Furthermore, the accreditation process verifies that the facility's hyperbaric chambers and other medical equipment meet stringent operational and maintenance standards. This ensures that the equipment is safe, functional, and capable of delivering the precise therapeutic conditions required for effective treatment. Patients can trust that they are receiving care from knowledgeable experts using reliable tools.

Adherence to Clinical Guidelines

The UHMS publishes the "Hyperbaric Oxygen Therapy Indications" report, which outlines the accepted medical uses for HBOT. An accredited facility adheres to these guidelines, ensuring that treatments are provided for conditions where HBOT has proven efficacy. This commitment to evidence-based practice means patients are less likely to receive HBOT for unproven claims, protecting them from ineffective and potentially costly treatments. The 14th edition of this report is a comprehensive guide for clinical practice, as referenced in UHMS-14thEd.indb. By choosing an accredited facility, patients are choosing a provider that aligns with the highest medical standards and practices.

Implications for Insurance Coverage

While UHMS accreditation does not guarantee insurance coverage, it significantly increases the likelihood that approved HBOT treatments will be covered. Insurance companies often look for treatments that are considered medically necessary and are provided by facilities adhering to recognized standards. An accredited facility treating UHMS-approved indications meets these criteria more often. This can be a major financial benefit for patients, as HBOT can involve multiple treatment sessions. Patients should always verify their specific insurance policy details, but choosing an accredited facility for an approved indication is a strong first step towards potential coverage.

Building Patient Trust

Ultimately, UHMS accreditation builds trust between patients and hyperbaric clinics. It provides a clear signal that a facility is committed to excellence, safety, and evidence-based medicine. In a field where patients may encounter various claims about HBOT, this independent validation from a respected medical society is invaluable. Patients can feel more secure in their treatment decisions, knowing that their chosen facility has met rigorous standards. This peace of mind is an important part of the healing process.

How Does Hyperbaric Oxygen Therapy Work for Approved Conditions?

Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen at pressures greater than 1 atmosphere absolute. This increased pressure allows more oxygen to dissolve into the blood plasma, which is normally not a primary carrier of oxygen. The extra oxygen can help heal tissues, fight infections, and reduce swelling throughout the body.

The Science Behind Increased Oxygen Delivery

Under normal atmospheric pressure, oxygen is primarily carried by red blood cells bound to hemoglobin. In a hyperbaric chamber, the increased pressure causes a much larger amount of oxygen to dissolve directly into the blood plasma, the liquid component of blood. This dissolved oxygen can then reach areas of the body where blood flow might be reduced due to injury or disease. For example, continuous intravenous infusion of oxygen at 10 mL/min has been reported as well tolerated in humans, while 20 mL/min caused symptoms, as detailed in the HBO Indications (2020) - Undersea & Hyperbaric Medical Society. This demonstrates the body's capacity to handle increased oxygen delivery, which HBOT leverages to a greater extent. The ability of HBOT to super-saturate the blood with oxygen is key to its therapeutic effects.

Promoting Healing and Tissue Repair

The high levels of oxygen delivered during HBOT play a crucial role in healing. Oxygen is essential for cell metabolism and tissue regeneration. In damaged or infected areas, blood flow can be compromised, leading to a lack of oxygen (hypoxia). HBOT counteracts this hypoxia by flooding the tissues with oxygen. This increased oxygen stimulates the growth of new blood vessels, a process called angiogenesis. It also promotes the activity of fibroblasts, cells that produce collagen, a vital component of connective tissue. This combined effect helps to repair damaged tissues, close wounds, and restore function. For conditions like problem wounds or compromised grafts, this enhanced healing capability is particularly valuable.

Fighting Infections

Many types of bacteria, especially those causing severe infections like gas gangrene and necrotizing soft tissue infections, thrive in low-oxygen environments. HBOT creates a high-oxygen environment that is toxic to these anaerobic bacteria, directly inhibiting their growth and survival. Moreover, increased oxygen levels enhance the ability of white blood cells to fight infection. Phagocytes, a type of white blood cell, need oxygen to effectively kill bacteria. By boosting oxygen availability, HBOT strengthens the body's natural immune response, making it a powerful adjunctive therapy for various infections. This dual action—direct antibacterial effect and immune system support—makes HBOT highly effective against certain difficult-to-treat infections.

Reducing Swelling and Inflammation

HBOT has anti-inflammatory effects that can help reduce swelling (edema) in injured tissues. The high partial pressure of oxygen causes vasoconstriction, meaning it narrows blood vessels. While this might seem counterintuitive, this reduction in blood flow helps to decrease swelling in injured areas while still ensuring that tissues receive ample oxygen through the dissolved oxygen in the plasma. Less swelling means less pressure on blood vessels, which can further improve blood flow and oxygen delivery to compromised tissues. This effect is particularly beneficial in conditions like crush injuries or acute traumatic ischemias, where swelling can severely impede healing and threaten tissue viability.

Other Therapeutic Mechanisms

Beyond these primary effects, HBOT also has other therapeutic mechanisms. It can help in cases of carbon monoxide poisoning by rapidly displacing carbon monoxide from hemoglobin and other proteins, allowing oxygen to bind instead. For air or gas embolism, the increased pressure in the chamber helps to shrink gas bubbles in the blood and tissues, allowing them to dissolve back into solution and be safely removed from the body. "Gas embolism occurs when gas bubbles enter arteries or veins," said Richard E. Moon in the "Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism" section of the UHMS, emphasizing the critical role of HBOT in addressing this dangerous condition by reducing bubble size and promoting their reabsorption. These diverse mechanisms illustrate why HBOT is a versatile treatment for a wide array of approved medical conditions.

What are Examples of Conditions Treated with HBOT?

One indication is air or gas embolism, which can result from various medical procedures or diving. Another is carbon monoxide poisoning, where HBOT helps remove carbon monoxide from the blood. Problem wounds, like diabetic foot ulcers, can also benefit from HBOT to enhance healing. These are just a few of the 14 conditions recognized by the UHMS.

Air or Gas Embolism: A Diving and Medical Risk

Air or gas embolism is a serious condition where gas bubbles enter the bloodstream. It is a common concern in diving, where venous gas embolism (VGE) occurs frequently after compressed gas diving, as noted in the HBO Indications (2020) - Undersea & Hyperbaric Medical Society. Normally, these bubbles are filtered by the lungs, but large volumes can cause symptoms like cough or dyspnea, or even cross into the arterial circulation. Arterial gas embolism (AGE) can occur from pulmonary barotrauma, such as from breath holding during an ascent of as little as one meter, according to the HBO Indications (2020) - Undersea & Hyperbaric Medical Society. Beyond diving, air embolism can arise from various medical procedures, including accidental intravenous air injection, cardiopulmonary bypass accidents, lung biopsies, hemodialysis, central venous catheter insertion, gastrointestinal endoscopy, and even certain surgical procedures like laparoscopy or craniotomy. HBOT is critical for these emergencies because the increased pressure helps to reduce the size of the gas bubbles, allowing them to dissolve and be safely eliminated from the body.

Carbon Monoxide Poisoning: A Silent Threat

Carbon monoxide (CO) is a deadly, odorless, and colorless gas. It is often produced by faulty heating systems, vehicle exhaust, or fires. When inhaled, CO binds to hemoglobin in red blood cells much more strongly than oxygen, effectively blocking oxygen transport to the body's tissues and organs. This leads to hypoxia, or oxygen starvation, which can damage the brain, heart, and other vital organs. HBOT is a primary treatment for carbon monoxide poisoning because it delivers 100% oxygen at increased pressure. This high concentration of oxygen helps to rapidly displace carbon monoxide from hemoglobin, allowing oxygen to bind instead. It also provides oxygen directly dissolved in the blood plasma, supplying critical oxygen to tissues even when hemoglobin is still occupied by CO. This swift action can significantly reduce the neurological and cardiac damage associated with CO poisoning.

Problem Wounds: Enhancing Healing

Problem wounds are chronic wounds that fail to heal despite standard medical care. These often include diabetic foot ulcers, pressure ulcers, and certain types of surgical wounds. Many of these wounds suffer from poor blood supply and chronic inflammation, leading to a lack of oxygen in the tissues. This hypoxic environment hinders the body's natural healing processes. HBOT addresses this by saturating the blood plasma with oxygen, which then reaches the wound bed. This increased oxygen promotes new blood vessel formation (angiogenesis), stimulates the growth of cells necessary for repair (fibroblasts), and enhances the activity of white blood cells to fight infection. For example, HBOT is indicated for the "Enhancement of Healing in Selected Problem Wounds," as stated in the 13th Edition of the UHMS Indications. By improving the oxygenation of the wound, HBOT can jumpstart the healing process and lead to successful closure of wounds that would otherwise persist. For more details, see UHMS HBO Indications: Air or Gas Embolism.

Compromised Grafts and Flaps: Saving Tissues

In reconstructive surgery, skin grafts and tissue flaps are used to cover wounds or replace lost tissue. The success of these procedures depends entirely on the graft or flap establishing a new blood supply from the recipient site. If blood flow is insufficient, the graft or flap can become compromised and die, leading to surgical failure and further complications. HBOT can be a crucial adjunctive therapy in these situations. By providing a super-oxygenated environment, HBOT improves oxygen delivery to the compromised tissues, even those with limited blood flow. This helps to reduce swelling, promote the formation of new capillaries, and increase the viability of the transplanted tissue. Early intervention with HBOT can significantly improve the chances of survival for compromised grafts and flaps, preventing tissue loss and improving patient outcomes.

Delayed Radiation Injuries: Repairing Damage

Radiation therapy is a powerful tool in cancer treatment, but it can sometimes cause damage to healthy tissues months or even years after treatment. These "delayed radiation injuries" can manifest as chronic non-healing wounds, osteoradionecrosis (bone death due to radiation), or damage to soft tissues. The underlying problem is often a reduction in blood supply and oxygen to the radiated area, leading to tissue breakdown. HBOT is used to treat these delayed effects by stimulating angiogenesis and increasing oxygenation in the damaged tissues. This helps to reverse some of the radiation-induced changes, promote healing, and reduce pain. For example, the 14th edition of the UHMS indications lists "Delayed Radiation Injuries (Soft Tissue and Bony Necrosis)" as an approved use for HBOT. By restoring blood flow and oxygen, HBOT can significantly improve the quality of life for patients suffering from these chronic complications.

Can HBOT Help with Conditions Not on the UHMS Approved List?

The UHMS list represents conditions for which there is sufficient scientific evidence for HBOT's effectiveness. Treatments for conditions not on this list may be considered "off-label" and might not be covered by insurance. Patients should consult with their healthcare provider and UHMS-accredited facilities for guidance.

Understanding "Off-Label" Use

When a medical treatment is used for a condition that is not specifically listed in the official indications by an authoritative body like the UHMS, it is considered "off-label" use. This means that while a physician might believe HBOT could be beneficial for a particular patient's condition, there may not be enough robust scientific evidence to formally recognize it as an approved indication. The UHMS emphasizes the importance of evidence-based practice, and their "Hyperbaric Oxygen Therapy Indications" report, now in its 14th edition, serves as the standard for approved uses. Therefore, while a physician might legally prescribe HBOT off-label, it is crucial for patients to understand that such uses do not have the same level of scientific backing or official recognition.

The Importance of Evidence-Based Indications

The UHMS's commitment to evidence-based medicine is paramount. The society's "Hyperbaric Oxygen Therapy Indications" report is the result of rigorous review by a committee of experts, like the Hyperbaric Oxygen Therapy Committee, which includes members who contribute to the 14th edition as outlined in UHMS-14thEd.indb. This committee evaluates scientific studies and clinical trials to determine if HBOT is consistently effective and safe for specific conditions. If there isn't enough high-quality evidence, a condition will not be added to the approved list. This strict approach protects patients from unproven treatments and ensures that HBOT is used responsibly where it has demonstrated benefit. It also helps to maintain the credibility of hyperbaric medicine as a whole.

Risks and Benefits of Off-Label Treatments

Considering HBOT for an off-label condition carries different considerations than for an approved indication. On one hand, some off-label uses may show promise in early research or individual case reports. Physicians may choose to offer such treatments if they believe the potential benefits outweigh the risks for a particular patient, especially when other treatments have failed. On the other hand, the lack of extensive research means the full range of risks, optimal dosing, and long-term effectiveness for off-label conditions are less understood. Patients should be fully informed about these uncertainties before pursuing off-label HBOT. It is important to remember that the Undersea and Hyperbaric Medical Society, in its Thirteenth Edition of Hyperbaric Oxygen Therapy Indications, explicitly states, "No responsibility is assumed by the Publisher or Editor for any injury and or damage to persons or property as a matter of product liability, negligence or otherwise, or from any use or operation of any methods, product, instructions, or ideas contained in the material herein." This statement underscores the critical need for individual medical judgment and verification.

Insurance Coverage and Costs

One significant practical implication of off-label HBOT use is insurance coverage. Most insurance providers, including government programs, primarily cover medical treatments that are considered "medically necessary" and are for FDA-approved devices and UHMS-approved indications. Since off-label uses lack formal recognition, they are much less likely to be covered by insurance. This means patients pursuing off-label HBOT will likely have to pay for the treatment out-of-pocket, which can be very expensive given that multiple sessions are often required. Patients should always discuss potential costs and insurance coverage thoroughly with their provider and insurance company before beginning any off-label treatment.

Consulting with Experts

If you are considering HBOT for a condition not on the UHMS approved list, it is essential to consult with a qualified healthcare provider, ideally one affiliated with a UHMS-accredited facility. These experts have the most up-to-date knowledge of hyperbaric medicine and can provide honest, evidence-based advice. They can discuss the current research, potential risks, and whether any clinical trials are available for your specific condition. They can also explain why certain conditions are not yet on the approved list and what future research might entail. Making an informed decision, with the guidance of experienced professionals, is always the best approach when exploring any medical treatment.

Frequently Asked Questions

What does UHMS stand for?

UHMS stands for the Undersea & Hyperbaric Medical Society. This organization is a leading authority in hyperbaric medicine, dedicated to research, education, and the development of clinical guidelines. They publish important documents like the "Hyperbaric Oxygen Therapy Indications," which is now in its 14th edition, as noted in UHMS-14thEd.indb.

How many conditions are approved for HBOT by the UHMS?

The UHMS recognizes 14 specific conditions as approved indications for hyperbaric oxygen therapy. These conditions are detailed in the "Hyperbaric Oxygen Therapy Indications" report, which guides medical professionals on the appropriate and evidence-based uses of HBOT. For example, air or gas embolism is one of these 14 indications.

Is hyperbaric oxygen therapy safe?

When administered in a UHMS-accredited facility by trained professionals, hyperbaric oxygen therapy is generally considered safe for approved indications. The FDA recommends UHMS-accredited facilities for specific illnesses, highlighting the importance of proper standards. Potential side effects are usually mild and temporary, but safety protocols are crucial.

Does insurance cover UHMS-approved HBOT treatments?

Insurance coverage for HBOT typically depends on whether the treatment is for a UHMS-approved indication and performed at a qualified facility. While UHMS accreditation does not guarantee coverage, it significantly increases the likelihood. Patients should always verify their specific policy with their insurance provider.

How can I find a UHMS-accredited hyperbaric facility?

To find a UHMS-accredited hyperbaric facility, you can often check the Undersea & Hyperbaric Medical Society's official website. They provide resources and information on their accreditation program, which helps patients locate facilities that meet their rigorous standards for safety and quality of care.

HBOT Regulation & Safety